Sign up to save your podcasts
Or
Share Episode 44 – Multi-system Inflammatory Syndrome in Children (MIS-C): An Interview with Dr. Ilene Claudius and Dr. Mohsen Saidinejad
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 44 – Multi-system Inflammatory Syndrome in Children (MIS-C): An Interview with Dr. Ilene Claudius and Dr. Mohsen Saidinejad
EMplify June 2020
Multi-system Inflammatory Syndrome in Children (MIS-C) with COVID-19: An Interview with Dr. Ilene Claudius and Dr. Mohsen Saidinejad.
What is it and when did we discover it as an entity?
Have either of you treated anyone with the disease?
Discussion of different cohorts of patients with MIS-C.
Definition of MIS-C.
Shock: cardiogenic and distributive shock presentations.
Fever, is 4 days required?
Discussion of where in the COVID-19 illness MIS-C occurs.
Is clinical shock a requirement?
Screening criteria (labs) and the Children’s Hospital Of Philadelphia pathway.
What is available as treatment?
A discussion of IVIG
Steroids
Cytokine blockers
Remdesivir
Why IVIG?
Complications of the disease.
Why are there more cases in New York?
How has MIS-C changed your practice of testing children?
Is there utility in testing for COVID-19 infection or antibodies in these cases?
Resources:EB Medicine Novel 2019 Coronavirus SARS-CoV-2 (COVID-19): An Updated Overview for Emergency Clinicians
EB Medicine COVID-19: The Impact on Pediatric Emergency Care
Children’s Hospital of Philadelphia Clinical Pathway for MIS-C.
Have questions or comments on the podcast? Leave us a voicemail at 678-336-8466, ext 128 or write us at [email protected] .
View all episodes
By EB Medicine
4.7
4646 ratings
EMplify June 2020
Multi-system Inflammatory Syndrome in Children (MIS-C) with COVID-19: An Interview with Dr. Ilene Claudius and Dr. Mohsen Saidinejad.
What is it and when did we discover it as an entity?
Have either of you treated anyone with the disease?
Discussion of different cohorts of patients with MIS-C.
Definition of MIS-C.
Shock: cardiogenic and distributive shock presentations.
Fever, is 4 days required?
Discussion of where in the COVID-19 illness MIS-C occurs.
Is clinical shock a requirement?
Screening criteria (labs) and the Children’s Hospital Of Philadelphia pathway.
What is available as treatment?
A discussion of IVIG
Steroids
Cytokine blockers
Remdesivir
Why IVIG?
Complications of the disease.
Why are there more cases in New York?
How has MIS-C changed your practice of testing children?
Is there utility in testing for COVID-19 infection or antibodies in these cases?
Resources:EB Medicine Novel 2019 Coronavirus SARS-CoV-2 (COVID-19): An Updated Overview for Emergency Clinicians
EB Medicine COVID-19: The Impact on Pediatric Emergency Care
Children’s Hospital of Philadelphia Clinical Pathway for MIS-C.
Have questions or comments on the podcast? Leave us a voicemail at 678-336-8466, ext 128 or write us at [email protected] .
More shows like EMplify by EB Medicine
View all
EMCrit FOAM Feed
1,869 Listeners
Emergency Medicine Cases
544 Listeners
JAMA Clinical Reviews
496 Listeners
Core EM - Emergency Medicine Podcast
260 Listeners
The Resus Room
97 Listeners
EM Clerkship
804 Listeners
The Curbsiders Internal Medicine Podcast
3,340 Listeners
Emergency Medical Minute
257 Listeners
Core IM | Internal Medicine Podcast
1,153 Listeners
The Clinical Problem Solvers
511 Listeners
Run the List
248 Listeners
Critical Care Scenarios
249 Listeners
The Curious Clinicians
370 Listeners
The Cribsiders
314 Listeners
Critical Care Time
231 Listeners